Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126404451 | 12640445 | 1 | I | 20160728 | 20160810 | 20160810 | EXP | JP-MYLANLABS-2016M1032200 | MYLAN | TSUTSUMI R, GODA M, FUJIMOTO C, KANNO K, NOBE M, KITAMURA Y, ET AL. EFFECTS OF CHEMOTHERAPY ON GENE EXPRESSION OF LINGUAL TASTE RECEPTORS IN PATIENTS WITH HEAD AND NECK CANCER. LARYNGOSCOPE 2016;126(3):E103-E109. | 0.00 | Y | 0.00000 | 20160810 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126404451 | 12640445 | 1 | PS | CISPLATIN. | CISPLATIN | 1 | Unknown | 80 MG/M2 | U | U | 91062 | ||||||||
| 126404451 | 12640445 | 2 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | 800 MG/M2, TWICE OVER 12 WEEKS | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126404451 | 12640445 | 1 | Head and neck cancer |
| 126404451 | 12640445 | 2 | Head and neck cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126404451 | 12640445 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126404451 | 12640445 | Stomatitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |